JAVMA news
Board acts on research, grievance resolution, residues
The AVMA Board of Directors, while meeting Nov. 20-22, 2014, approved a few new policies, rescinded some that were no longer, and reaffirmed or…
AVMA news
Advances in animal genome editing continue apace
The Food and Drug Administration (FDA) recently green lit for human consumption five genetically modified pigs at Washington State University.…
JAVMA news
Editing Animals
Recent gene-editing technologies are being used to create mice that model human genetic diseases, Holstein cattle lacking horns, and current research…
JAVMA news
Academic groups seek easier approval path for gene-edited food animals
Two academic groups argue that the amount of regulatory oversight for genetic changes in food animals should depend on the nature of the changes, and…
JAVMA news
COVID vaccine an immunological moonshot
Developing and distributing a vaccine for a novel coronavirus that has killed more than a million people globally has the potential of becoming the…
JAVMA news
Finding a future for osteosarcoma patients
Ana M. Cilursu, MD, lost three Rottweilers in a row to bone cancer.
JAVMA news
Vaccine holds promise for treating osteosarcoma in dogs
Veterinarians in the audience wanted to know when they could get their hands on the new treatment. Dr. Sue Ettinger, a veterinary oncologist, had…
JAVMA news
A glimmer of hope for a fatal feline disease
Controlling risk factors for feline infectious peritonitis is difficult, while new antiviral drugs show great promise
JAVMA news
Summit paints mixed economic picture for practitioners
There’s good news: Revenues are growing at many veterinary practices.There's mixed news: The AVMA Veterinary Career Center now has more jobs than…